Amgen (AMGN)
(Delayed Data from NSDQ)
$334.85 USD
+0.55 (0.16%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $334.92 +0.07 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Brokerage Reports
Amgen Inc. [AMGN]
Reports for Purchase
Showing records 401 - 420 ( 433 total )
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Raising our CY12 & CY13 estimates in view of strong performance in Q1 CY12...
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
1Q12 results beat expectations despite ESA franchise declines; SELL
Provider: LAZARD
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
ODAC panel not swayed by Xgeva BMFS data - vote 12-1 against approving indication; SELL
Provider: LAZARD
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Xgeva/Prolio likely to become key growth driver ahead & expected to drive high single digit earnings growth...
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Xgeva/Prolio likely to be a key driver & help record high single-digit earnings growth...
Provider: FIRST GLOBAL
Analyst: THOMAS K